| Literature DB >> 24582094 |
Guido Lastra1, Sofia Syed2, L Romayne Kurukulasuriya3, Camila Manrique1, James R Sowers4.
Abstract
Patients with hypertension and type 2 diabetes are at increased risk of cardiovascular and chronic renal disease. Factors involved in the pathogenesis of both hypertension and type 2 diabetes include inappropriate activation of the renin-angiotensin-aldosterone system, oxidative stress, inflammation, impaired insulin-mediated vasodilatation, augmented sympathetic nervous system activation, altered innate and adaptive immunity, and abnormal sodium processing by the kidney. The renin-angiotensin-aldosterone system blockade is a key therapeutic strategy in the treatment of hypertension in type 2 diabetes. Emerging therapies for resistant hypertension as often exists in patients with diabetes, include renal denervation and carotid body denervation.Entities:
Keywords: Cardiovascular disease; Chronic kidney disease; Diabetes; Hypertension; Renin-angiotensin-aldosterone system; Sympathetic nervous system
Mesh:
Year: 2013 PMID: 24582094 PMCID: PMC3942662 DOI: 10.1016/j.ecl.2013.09.005
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741